The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ertapenem Sodium Market Research Report 2025
Synopsis
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
The global Ertapenem Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ertapenem Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ertapenem Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ertapenem Sodium include Tecoland, Qilu Pharmaceutical, Beijing Lunarsun Pharmaceutical, Savior Lifetec Corporation, Zhejiang New Donghai Pharmaceutical, Iffect Chemphar and Sun Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ertapenem Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Sodium.
Report Scope
The Ertapenem Sodium market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ertapenem Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ertapenem Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tecoland
Qilu Pharmaceutical
Beijing Lunarsun Pharmaceutical
Savior Lifetec Corporation
Zhejiang New Donghai Pharmaceutical
Iffect Chemphar
Sun Pharma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Ertapenem Sodium Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ertapenem Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ertapenem Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ertapenem Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
The global Ertapenem Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ertapenem Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ertapenem Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ertapenem Sodium include Tecoland, Qilu Pharmaceutical, Beijing Lunarsun Pharmaceutical, Savior Lifetec Corporation, Zhejiang New Donghai Pharmaceutical, Iffect Chemphar and Sun Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ertapenem Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Sodium.
Report Scope
The Ertapenem Sodium market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ertapenem Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ertapenem Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tecoland
Qilu Pharmaceutical
Beijing Lunarsun Pharmaceutical
Savior Lifetec Corporation
Zhejiang New Donghai Pharmaceutical
Iffect Chemphar
Sun Pharma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Ertapenem Sodium Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ertapenem Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ertapenem Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ertapenem Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Ertapenem Sodium Market Overview
1.1 Product Definition
1.2 Ertapenem Sodium Segment by Type
1.2.1 Global Ertapenem Sodium Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Ertapenem Sodium Segment by Application
1.3.1 Global Ertapenem Sodium Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Ertapenem Sodium Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Ertapenem Sodium Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ertapenem Sodium Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ertapenem Sodium Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ertapenem Sodium Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ertapenem Sodium Production Market Share by Manufacturers (2019-2024)
2.2 Global Ertapenem Sodium Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ertapenem Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ertapenem Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ertapenem Sodium Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ertapenem Sodium, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ertapenem Sodium, Product Offered and Application
2.8 Global Key Manufacturers of Ertapenem Sodium, Date of Enter into This Industry
2.9 Ertapenem Sodium Market Competitive Situation and Trends
2.9.1 Ertapenem Sodium Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ertapenem Sodium Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ertapenem Sodium Production by Region
3.1 Global Ertapenem Sodium Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ertapenem Sodium Production Value by Region (2019-2030)
3.2.1 Global Ertapenem Sodium Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ertapenem Sodium by Region (2025-2030)
3.3 Global Ertapenem Sodium Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ertapenem Sodium Production by Region (2019-2030)
3.4.1 Global Ertapenem Sodium Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ertapenem Sodium by Region (2025-2030)
3.5 Global Ertapenem Sodium Market Price Analysis by Region (2019-2024)
3.6 Global Ertapenem Sodium Production and Value, Year-over-Year Growth
3.6.1 North America Ertapenem Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ertapenem Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ertapenem Sodium Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ertapenem Sodium Production Value Estimates and Forecasts (2019-2030)
4 Ertapenem Sodium Consumption by Region
4.1 Global Ertapenem Sodium Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ertapenem Sodium Consumption by Region (2019-2030)
4.2.1 Global Ertapenem Sodium Consumption by Region (2019-2024)
4.2.2 Global Ertapenem Sodium Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ertapenem Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ertapenem Sodium Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ertapenem Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ertapenem Sodium Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ertapenem Sodium Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ertapenem Sodium Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ertapenem Sodium Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ertapenem Sodium Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ertapenem Sodium Production by Type (2019-2030)
5.1.1 Global Ertapenem Sodium Production by Type (2019-2024)
5.1.2 Global Ertapenem Sodium Production by Type (2025-2030)
5.1.3 Global Ertapenem Sodium Production Market Share by Type (2019-2030)
5.2 Global Ertapenem Sodium Production Value by Type (2019-2030)
5.2.1 Global Ertapenem Sodium Production Value by Type (2019-2024)
5.2.2 Global Ertapenem Sodium Production Value by Type (2025-2030)
5.2.3 Global Ertapenem Sodium Production Value Market Share by Type (2019-2030)
5.3 Global Ertapenem Sodium Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ertapenem Sodium Production by Application (2019-2030)
6.1.1 Global Ertapenem Sodium Production by Application (2019-2024)
6.1.2 Global Ertapenem Sodium Production by Application (2025-2030)
6.1.3 Global Ertapenem Sodium Production Market Share by Application (2019-2030)
6.2 Global Ertapenem Sodium Production Value by Application (2019-2030)
6.2.1 Global Ertapenem Sodium Production Value by Application (2019-2024)
6.2.2 Global Ertapenem Sodium Production Value by Application (2025-2030)
6.2.3 Global Ertapenem Sodium Production Value Market Share by Application (2019-2030)
6.3 Global Ertapenem Sodium Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Tecoland
7.1.1 Tecoland Ertapenem Sodium Corporation Information
7.1.2 Tecoland Ertapenem Sodium Product Portfolio
7.1.3 Tecoland Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Tecoland Main Business and Markets Served
7.1.5 Tecoland Recent Developments/Updates
7.2 Qilu Pharmaceutical
7.2.1 Qilu Pharmaceutical Ertapenem Sodium Corporation Information
7.2.2 Qilu Pharmaceutical Ertapenem Sodium Product Portfolio
7.2.3 Qilu Pharmaceutical Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Qilu Pharmaceutical Main Business and Markets Served
7.2.5 Qilu Pharmaceutical Recent Developments/Updates
7.3 Beijing Lunarsun Pharmaceutical
7.3.1 Beijing Lunarsun Pharmaceutical Ertapenem Sodium Corporation Information
7.3.2 Beijing Lunarsun Pharmaceutical Ertapenem Sodium Product Portfolio
7.3.3 Beijing Lunarsun Pharmaceutical Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Beijing Lunarsun Pharmaceutical Main Business and Markets Served
7.3.5 Beijing Lunarsun Pharmaceutical Recent Developments/Updates
7.4 Savior Lifetec Corporation
7.4.1 Savior Lifetec Corporation Ertapenem Sodium Corporation Information
7.4.2 Savior Lifetec Corporation Ertapenem Sodium Product Portfolio
7.4.3 Savior Lifetec Corporation Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Savior Lifetec Corporation Main Business and Markets Served
7.4.5 Savior Lifetec Corporation Recent Developments/Updates
7.5 Zhejiang New Donghai Pharmaceutical
7.5.1 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Corporation Information
7.5.2 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Product Portfolio
7.5.3 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Zhejiang New Donghai Pharmaceutical Main Business and Markets Served
7.5.5 Zhejiang New Donghai Pharmaceutical Recent Developments/Updates
7.6 Iffect Chemphar
7.6.1 Iffect Chemphar Ertapenem Sodium Corporation Information
7.6.2 Iffect Chemphar Ertapenem Sodium Product Portfolio
7.6.3 Iffect Chemphar Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Iffect Chemphar Main Business and Markets Served
7.6.5 Iffect Chemphar Recent Developments/Updates
7.7 Sun Pharma
7.7.1 Sun Pharma Ertapenem Sodium Corporation Information
7.7.2 Sun Pharma Ertapenem Sodium Product Portfolio
7.7.3 Sun Pharma Ertapenem Sodium Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Sun Pharma Main Business and Markets Served
7.7.5 Sun Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ertapenem Sodium Industry Chain Analysis
8.2 Ertapenem Sodium Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ertapenem Sodium Production Mode & Process
8.4 Ertapenem Sodium Sales and Marketing
8.4.1 Ertapenem Sodium Sales Channels
8.4.2 Ertapenem Sodium Distributors
8.5 Ertapenem Sodium Customers
9 Ertapenem Sodium Market Dynamics
9.1 Ertapenem Sodium Industry Trends
9.2 Ertapenem Sodium Market Drivers
9.3 Ertapenem Sodium Market Challenges
9.4 Ertapenem Sodium Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
